{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:39:56Z","timestamp":1789195196520,"version":"build-2803163510"},"reference-count":103,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Upper gastrointestinal (GI) cancers are responsible for significant mortality and morbidity worldwide. To date, most of the studies focused on the treatments\u2019 efficacy and post-treatment survival rate. As treatments improve, more patients survive long term, and thus the accompanying complications including unintentional weight loss are becoming more important. Unintentional weight loss is defined as &gt;5% of body weight loss within 6\u201312 months. Malignancies, particularly GI cancers, are diagnosed in approximately 25% of patients who present with unintentional weight loss. Whereas some recent studies discuss pathophysiological mechanisms and new promising therapies of cancer cachexia, there is a lack of studies regarding the underlying mechanism of unintentional weight loss in patients who are tumor free and where cancer cachexia has been excluded. The small bowel is a central hub in metabolic regulation, energy homeostasis, and body weight control throughout the microbiota-gut-brain axis. In this narrative review article, the authors discussed the impacts of upper GI cancers\u2019 treatment modalities on the small bowel which may lead to unintentional weight loss and some new promising therapeutic agents to treat unintentional weight loss in long term survivors after upper GI operations with curative intent.<\/jats:p>","DOI":"10.3390\/jcm8070942","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:20:26Z","timestamp":1561720826000},"page":"942","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of the Small Bowel in Unintentional Weight Loss after Treatment of Upper Gastrointestinal Cancers"],"prefix":"10.3390","volume":"8","author":[{"given":"Babak","family":"Dehestani","sequence":"first","affiliation":[{"name":"Diabetes Complications Research Centre, University College Dublin, D04 HV52 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W","family":"le Roux","sequence":"additional","affiliation":[{"name":"Diabetes Complications Research Centre, University College Dublin, D04 HV52 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/annonc\/mdn741","article-title":"Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen","volume":"20","author":"Bitik","year":"2009","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"52307","DOI":"10.18632\/oncotarget.10740","article-title":"Metastatic spread in patients with gastric cancer","volume":"7","author":"Riihimaki","year":"2016","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.3748\/wjg.15.2665","article-title":"Bone and brain metastases from ampullary adenocarcinoma","volume":"15","author":"Voutsadakis","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/CMAR.S150350","article-title":"Sites of metastasis and overall survival in esophageal cancer: A population-based study","volume":"9","author":"Wu","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5858\/133.3.413","article-title":"The pathology and genetics of metastatic pancreatic cancer","volume":"133","author":"Yachida","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/CMAR.S101169","article-title":"Multidisciplinary management for esophageal and gastric cancer","volume":"8","author":"Boniface","year":"2016","journal-title":"Cancer Manag. Res."},{"key":"ref_8","first-page":"698","article-title":"Treatment strategies in gastric cancer","volume":"108","author":"Meyer","year":"2011","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1586\/14737140.8.6.975","article-title":"Upper gastrointestinal tumors: Current status and future perspectives","volume":"8","author":"Jiang","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(03)12141-1","article-title":"Guidelines for treatment of upper gastrointestinal cancer","volume":"361","author":"Forman","year":"2003","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10147-011-0362-8","article-title":"Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: A prospective cohort study","volume":"18","author":"Spaander","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1245\/s10434-008-9929-7","article-title":"Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer","volume":"15","author":"Pawlik","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Baicus, C., Rimbas, M., Baicus, A., and Caraiola, S. (2014). Cancer and involuntary weight loss: Failure to validate a prediction score. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095286"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejim.2005.01.004","article-title":"The diagnostic spectrum of unintentional weight loss","volume":"16","author":"Vanderschueren","year":"2005","journal-title":"Eur. J. Intern. Med."},{"key":"ref_15","first-page":"539","article-title":"Prognostic significance of unintentional body weight loss in colon cancer patients","volume":"8","author":"Kuo","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jjco\/hys212","article-title":"Prognostic value of body mass index for patients undergoing esophagectomy for esophageal squamous cell carcinoma","volume":"43","author":"Cheng","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00268-010-0697-8","article-title":"Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer","volume":"34","author":"Grotenhuis","year":"2010","journal-title":"World J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000093756","article-title":"Nutritional status as a risk factor in esophageal surgery","volume":"23","author":"Hop","year":"2006","journal-title":"Dig. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1245\/s10434-013-3073-8","article-title":"Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus","volume":"20","author":"Watanabe","year":"2013","journal-title":"Ann. Surg Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1038\/bjc.2013.666","article-title":"The impact of body mass index on complication and survival in resected oesophageal cancer: A clinical-based cohort and meta-analysis","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcsm.12010","article-title":"Understanding and managing cancer-related weight loss and anorexia: Insights from a systematic review of qualitative research","volume":"6","author":"Cooper","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0884533617722986","article-title":"Cancer Cachexia: Cause, Diagnosis, and Treatment","volume":"32","author":"Mattox","year":"2017","journal-title":"Nutr. Clin. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/physrev.00021.2017","article-title":"Food Intake and Eating Behavior after Bariatric Surgery","volume":"98","author":"Docherty","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_28","first-page":"203","article-title":"The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Quigley, E.M.M. (2018). The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS). J. Clin. Med., 7.","DOI":"10.3390\/jcm7010006"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"53829","DOI":"10.18632\/oncotarget.17754","article-title":"Microbiota-gut-brain axis and the central nervous system","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2613.2011.00767.x","article-title":"Classification and functions of enteroendocrine cells of the lower gastrointestinal tract","volume":"92","author":"Gunawardene","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1210\/jc.2005-0409","article-title":"Peptide YY is secreted after oral glucose administration in a gender-specific manner","volume":"90","author":"Kim","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s004240050913","article-title":"Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat","volume":"438","author":"Anini","year":"1999","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fnins.2017.00617","article-title":"Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System","volume":"11","author":"Mertens","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.livres.2017.12.007","article-title":"Bile acid signaling and bariatric surgery","volume":"1","author":"Tian","year":"2017","journal-title":"Liver Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000371699","article-title":"Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?","volume":"33","author":"Kohli","year":"2015","journal-title":"Dig. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2014.00085","article-title":"The SCFA Receptor GPR43 and Energy Metabolism","volume":"5","author":"Kimura","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fendo.2014.00081","article-title":"Regulation of Energy Homeostasis by GPR41","volume":"5","author":"Inoue","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000658-198908000-00005","article-title":"Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy","volume":"210","author":"Miholic","year":"1989","journal-title":"Ann. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11695-013-1166-x","article-title":"The effect of bariatric surgery on intestinal absorption and transit time","volume":"24","author":"Carswell","year":"2014","journal-title":"Obes. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2354.2006.00709.x","article-title":"Patients\u2019 subjective symptoms, quality of life and intake of food during the recovery period 3 and 12 months after upper gastrointestinal surgery","volume":"16","author":"Olsson","year":"2007","journal-title":"Eur. J. Cancer Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/j.gastro.2009.11.012","article-title":"Gastric bypass increases energy expenditure in rats","volume":"138","author":"Bueter","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s00125-015-3696-3","article-title":"Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes","volume":"58","author":"Rhee","year":"2015","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hansen, C.F., Bueter, M., Theis, N., Lutz, T., Paulsen, S., Dalb\u00f8ge, L.S., Vrang, N., and Jelsing, J. (2013). Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065696"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/SLA.0000000000001918","article-title":"Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study","volume":"266","author":"Elliott","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0000000000001465","article-title":"Gut Hormone Suppression Increases Food Intake After Esophagectomy With Gastric Conduit Reconstruction","volume":"262","author":"Elliott","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2011-2145","article-title":"The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control","volume":"153","author":"Pournaras","year":"2012","journal-title":"Endocrinology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","article-title":"Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation","volume":"22","author":"Tremaroli","year":"2015","journal-title":"Cell Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"15228","DOI":"10.1038\/s41598-017-15079-0","article-title":"Clinical Parameters and Gut Microbiome Changes Before and After Surgery in Thoracic Aortic Dissection in Patients with Gastrointestinal Complications","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lederer, A.K., Pisarski, P., Kousoulas, L., Fichtner-Feigl, S., Hess, C., and Huber, R. (2017). Postoperative changes of the microbiome: Are surgical complications related to the gut flora? A systematic review. BMC Surg., 17.","DOI":"10.1186\/s12893-017-0325-8"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.sla.0000118561.54919.61","article-title":"Ghrelin: Integrative neuroendocrine peptide in health and disease","volume":"239","author":"Wu","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","article-title":"Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans","volume":"141","author":"Date","year":"2000","journal-title":"Endocrinology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1210\/jcem.85.12.7167","article-title":"Ghrelin strongly stimulates growth hormone release in humans","volume":"85","author":"Takaya","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/jcem.86.9.8002","article-title":"A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans","volume":"86","author":"Hataya","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","article-title":"The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion","volume":"141","author":"Wren","year":"2000","journal-title":"Endocrinology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/B978-0-12-381272-8.00026-X","article-title":"Clinical trial of ghrelin synthesis administration for upper GI surgery","volume":"514","author":"Takiguchi","year":"2012","journal-title":"Methods Enzymol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","article-title":"Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction","volume":"148","author":"Yamamoto","year":"2010","journal-title":"Surgery"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.10199","article-title":"Postoperative taste and smell deficit after upper gastrointestinal cancer surgery\u2014An unreported complication","volume":"82","author":"Harris","year":"2003","journal-title":"J. Surg. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2018.00104","article-title":"From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation","volume":"12","author":"Bajic","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Nam, Y.D., Kim, H.J., Seo, J.G., Kang, S.W., and Bae, J.W. (2013). Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082659"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","article-title":"Systematic review: The role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis\u2014Current evidence and potential clinical applications","volume":"40","author":"Touchefeu","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kumagai, T., Rahman, F., and Smith, A.M. (2018). The Microbiome and Radiation Induced-Bowel Injury: Evidence for Potential Mechanistic Role in Disease Pathogenesis. Nutrients, 10.","DOI":"10.3390\/nu10101405"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4161\/cbt.3.8.1030","article-title":"Somatostatin and cancer: Applying endocrinology to oncology","volume":"3","author":"Grimberg","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Li, S.-C., Martijn, C., Cui, T., Essaghir, A., Luque, R.M., Demoulin, J.-B., Casta\u00f1o, J.P., \u00d6berg, K., and Giandomenico, V. (2012). The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048411"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajcn\/nqy324","article-title":"Attenuation of satiety gut hormones increases appetitive behavior after curative esophagectomy for esophageal cancer","volume":"109","author":"Elliott","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1530\/ERC-16-0151","article-title":"Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: Past, present and future","volume":"23","author":"Oberg","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2265.1999.00819.x","article-title":"Long-term results of octreotide-therapy in severe dumping syndrome","volume":"51","author":"Vecht","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00000658-199012000-00005","article-title":"Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome","volume":"212","author":"Geer","year":"1990","journal-title":"Ann. Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9610(91)90381-M","article-title":"Why does somatostatin cause gallstones?","volume":"161","author":"Ahrendt","year":"1991","journal-title":"Am. J. Surg."},{"key":"ref_76","first-page":"1042","article-title":"Octreotide-associated biliary tract dysfunction and gallstone formation: Pathophysiology and management","volume":"90","author":"Redfern","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: An integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials","volume":"16","author":"Boccia","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: A multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Supportive Care Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: Results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Supportive Care Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","article-title":"Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC","volume":"16","author":"Zhang","year":"2015","journal-title":"Expert Opin. Pharm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/17446651.2016.1245140","article-title":"Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake","volume":"11","author":"Elliott","year":"2016","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas Cancer-Associated Weight Loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncologist"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1530\/eje.0.151s071","article-title":"Novel analogs of ghrelin: Physiological and clinical implications","volume":"151","author":"Halem","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/vms3.83","article-title":"Capromorelin: A ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs","volume":"4","author":"Rhodes","year":"2018","journal-title":"Vet. Med. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000442907","article-title":"Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers","volume":"2","author":"Reim","year":"2016","journal-title":"Gastrointest. Tumors"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000445188","article-title":"Nutrition in Patients with Gastric Cancer: An Update","volume":"2","author":"Rosania","year":"2016","journal-title":"Gastrointest. Tumors"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"30919","DOI":"10.18632\/oncotarget.25778","article-title":"Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement","volume":"9","author":"Ichim","year":"2018","journal-title":"Oncotarget"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fendo.2013.00103","article-title":"Glutamate and GABA in Appetite Regulation","volume":"4","author":"Delgado","year":"2013","journal-title":"Front. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2013.09.009","article-title":"Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP","volume":"18","author":"Krashes","year":"2013","journal-title":"Cell Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/en.2008-1706","article-title":"Pegylated leptin antagonist is a potent orexigenic agent: Preparation and mechanism of activity","volume":"150","author":"Elinav","year":"2009","journal-title":"Endocrinology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2015.04.015","article-title":"Diet-induced obese mice retain endogenous leptin action","volume":"21","author":"Ottaway","year":"2015","journal-title":"Cell Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1210\/en.2011-0185","article-title":"Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance","volume":"152","author":"Levi","year":"2011","journal-title":"Endocrinology"},{"key":"ref_93","first-page":"314","article-title":"MC4 receptor antagonists: A potential treatment for cachexia","volume":"8","author":"Foster","year":"2005","journal-title":"Idrugs Investig. Drugs J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2174\/156802607780906663","article-title":"Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexia","volume":"7","author":"Foster","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-011-0039-1","article-title":"The orally active melanocortin-4 receptor antagonist BL-6020\/979: A promising candidate for the treatment of cancer cachexia","volume":"2","author":"Dallmann","year":"2011","journal-title":"J. Cachexiasarcopenia Muscle"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1756283X15607414","article-title":"Fecal microbiota transplantation: In perspective","volume":"9","author":"Gupta","year":"2016","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-018-0627-8","article-title":"Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation","volume":"20","author":"Jeon","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/JIR.S176190","article-title":"Fecal microbiota transplant\u2014A new frontier in inflammatory bowel disease","volume":"11","author":"Sunkara","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nmo.12479","article-title":"Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?","volume":"27","author":"Pinn","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal microbiota transplantation in metabolic syndrome: History, present and future","volume":"8","author":"Frissen","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/19490976.2017.1286006","article-title":"Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review","volume":"8","author":"Woodworth","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"ofv004","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/7\/942\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:16Z","timestamp":1760187736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/7\/942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":103,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["jcm8070942"],"URL":"https:\/\/doi.org\/10.3390\/jcm8070942","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]}}}